Gene:
Hepatocellular carcinoma-associated antigen 58 homolog (DBSS)
Gene ID:
168610
Symbol:
RGD1305020_predicted
Species:
1182
Description:
Survival of patients with GLEA2 antibodies was increased to 17.4 months and for patients with PHF3 antibodies to 14.7 months, as compared to 7.2 months for patients without GLEA2 or PHF3 antibodies in glioblastoma